Quantifying the impact of introducing HPV vaccines in 2006 on 25-29-year-old cervical cancer incidence in 2022
JNCI Cancer Spectrum · 30.04.2025 · 9 (3)
DOI: 10.1093/jncics/pkaf059 ↗Kurz gefasst
Fachartikel in der Zeitschrift JNCI Cancer Spectrum, online erschienen am 10.06.2025. Verfasst von Jason Semprini und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Public Health, College of Health Sciences, Des Moines University, West Des Moines, IA, United States. Hauptthemen laut MEDLINE: Papillomavirus Vaccines, Uterine Cervical Neoplasms, Papillomavirus Infections. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Nearly all cervical cancers are caused by human papillomavirus (HPV). In 2006, adolescent females were recommended to receive the HPV vaccine. Our study aimed to quantify the impact of introducing the HPV vaccine in 2006 on cervical cancer incidence in 2022. We analyzed the latest Surveillance, Epidemiology, and End Results data. Our design compared the change in cervical cancer incidence from 2019 to 2022 between females recommended for HPV vaccination in 2006 (age 25-29) and females who were not (age 35-54). Beyond simple pre/post comparisons, our linear regression model adjusted for age-specific incidence trends. We found that, unlike the stagnate trends in older females between 2019 and 2022, in 25-29-year-old females, cervical cancer incidence declined 2.1 cases/100 000 (95% CI = −2.7 to −1.6): a 48% reduction from baseline trends. Although tempered by uneven adherence, after 15 years we finally appear to be realizing quantifiable benefits from this cancer prevention vaccine.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Public Health, College of Health Sciences, Des Moines University, West Des Moines, IA, United States.
ORCID-Profile: Jason Semprini, Joshua Devine
Zitieren
APA
Semprini, J., Devine, J., & Reimer, R. (2025). Quantifying the impact of introducing HPV vaccines in 2006 on 25-29-year-old cervical cancer incidence in 2022. JNCI Cancer Spectrum, 9(3). https://doi.org/10.1093/jncics/pkaf059
Vancouver
Semprini J, Devine J, Reimer R. Quantifying the impact of introducing HPV vaccines in 2006 on 25-29-year-old cervical cancer incidence in 2022. JNCI Cancer Spectrum. 2025;9(3). doi:10.1093/jncics/pkaf059
BibTeX
@article{Semprini2025,
author = {Semprini, Jason and Devine, Joshua and Reimer, Rachel},
title = {Quantifying the impact of introducing HPV vaccines in 2006 on 25-29-year-old cervical cancer incidence in 2022},
journal = {JNCI Cancer Spectrum},
year = {2025},
volume = {9},
number = {3},
doi = {10.1093/jncics/pkaf059}
}
EUVIMED